AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Solid Tumor (Phase 1)

A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration NCT07718165Phase 11 site๐Ÿ“ Shanghai Abbisko Therapeutics Co, Ltd ยท Tests: ABSK211 Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment NCT05661461Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ West Valley City Aadi Bioscience, Inc. ยท Tests: nab-sirolimus A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma๏ผˆKeyplus-001๏ผ‰ NCT05357651Phase 11 site๐Ÿ“ Shanghai L & L Bio Co., Ltd., Ningbo, China ยท Tests: LB1410 A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors NCT06349811Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M05D1 MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site๐Ÿ“ Hangzhou Zhejiang University ยท Tests: MT027 CAR-T cells ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites๐Ÿ“ San Diego๐Ÿ“ Denver๐Ÿ“ Nashville Acepodia Biotech, Inc. ยท Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites๐Ÿ“ Los Angeles๐Ÿ“ New Haven๐Ÿ“ New Haven Pfizer ยท Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site๐Ÿ“ Shanghai Hansoh BioMedical R&D Company ยท Tests: HS-20108 Monotherapy Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection NCT05620017Phase 12 sites๐Ÿ“ Chongqing๐Ÿ“ Hangzhou Bio-Thera Solutions ยท Tests: BAT8008 for Injection A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors NCT06716138Phase 15 sites๐Ÿ“ New York๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Avistone Biotechnology Co., Ltd. ยท Tests: ANS03 A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. NCT06487455Phase 16 sites๐Ÿ“ Changsha๐Ÿ“ Fuzhou๐Ÿ“ Hangzhou Shanghai Pharmaceuticals Holding Co., Ltd ยท Tests: SPH7485 COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226Phase 1, Phase 21 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metfโ€ฆ A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors NCT05836324Phase 139 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Boston Incyte Corporation ยท Tests: INCA33890, bevacizumab, FOLFIRI, FOLFOX, Cetuximab CW-301 FIH Study of CAN016 NCT07664150Phase 1, Phase 21 site๐Ÿ“ Beijing Canwell Biotech Limited ยท Tests: CAN016, CAN016 A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies NCT06994806Phase 115 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Denver Kumquat Biosciences Inc. ยท Tests: KQB168, Pembrolizumab Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors NCT07387068Phase 112 sites๐Ÿ“ New Haven๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success Genmab ยท Tests: GEN1079 Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors NCT07644650Phase 11 site๐Ÿ“ Shanghai Mabsoft Therapeutics (Shanghai) Co., Ltd. ยท Tests: MST-168 Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites๐Ÿ“ Fairway๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Metarrestin A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Birmingham Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046054, pembrolizumab Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors NCT06598800Phase 134 sites๐Ÿ“ Hackensack๐Ÿ“ Houston๐Ÿ“ Fairfax BeOne Medicines ยท Tests: Drug: BG-T187, Other Therapeutic Agents Safety and Activity of HF50 in Patients With Advanced Solid Tumors NCT07601334Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou HighField Biopharmaceuticals Corporation ยท Tests: HF50 JSKN022 in Subjects With Advanced Malignant Solid Tumors NCT07292402Phase 11 site๐Ÿ“ Guangzhou Jiangsu Alphamab Biopharmaceuticals Co., Ltd ยท Tests: JSKN022 A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. NCT07356453Phase 18 sites๐Ÿ“ Palo Alto๐Ÿ“ San Francisco๐Ÿ“ Grand Rapids FoRx Therapeutics AG ยท Tests: FORX-428 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma NCT04389281Phase 14 sites๐Ÿ“ Washington D.C.๐Ÿ“ Charlotte๐Ÿ“ Durham Immunolight, LLC ยท Tests: X-PACT A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors NCT07165067Phase 13 sites๐Ÿ“ Waratah๐Ÿ“ Brisbane๐Ÿ“ Melbourne AP Biosciences Inc. ยท Tests: AP601 Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors NCT06724016Phase 17 sites๐Ÿ“ Boston๐Ÿ“ Detroit๐Ÿ“ Seongnam-si Hanmi Pharmaceutical Company Limited ยท Tests: HM16390, pembrolizumab Study of MHB088C for Patients With Advanced Solid Malignant Tumors NCT07102004Phase 1, Phase 21 site๐Ÿ“ Beijing Qilu Pharmaceutical Co., Ltd. ยท Tests: MHB088C for Injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy